Search Results 1951-1960 of 17638 for rheumatoid arthritis

  1. A Roche Cancer Screening Study - Mayo Clinic

    Currently taking any anti-neoplastic treatment or disease-modifying anti-rheumatic drugs (DMARDs). Currently receiving treatment for pneumonia, or had a ...

  2. Piperacillin and tazobactam (intravenous route) - Mayo Clinic

    Piperacillin and tazobactam combination injection is used to treat bacterial infections in many different parts of the body (eg, stomach or bowel, lungs, skin, ...

  3. Publications

    Nanda S, Mack KJ. Multiple promoters direct stimulus and temporal specific expression of brain-derived neurotrophic factor in the somatosensory cortex. Brain ...

  4. Back pain - Doctors and departments - Mayo Clinic

    Stephen J. Wisniewski, M.D.. Sports Medicine Specialist; Physiatrist. Rochester, MN. Areas of focus: Sport specific rehabilitation, Arthritis rehabilitation, ...

  5. Meet our team - Limb and Musculoskeletal Regenerative Research: Mimi C. Sammarco, Ph.D. - Mayo Clinic Research

    Rupp is a scientist trained in the fields of immunology and rheumatology. She grew up in Austria, where she completed a master's degree in biochemistry and ...

  6. Mayo Clinic clinical trials in patients with tumor-induced osteomalacia

    ... with patients with oncogenic osteomalacia: identification of the disease and the localization of the tumor-producing fibroblast growth factor 23 (FGF23).

  7. Achilles tendinitis - Doctors and departments - Mayo Clinic

    ... arthritis, Hip tendinitis, Knee arthritis, Ankle instability, Shoulder arthritis. Show more areas of focus for Callie M. Davies, M.D. ...

  8. Hematology - Department home - Mayo Clinic

    Mayo Clinic hematologists are experts in treating blood cancers and non-cancerous blood disorders. From the most common to incredibly rare hematologic ...

  9. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

    A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) ...

  10. A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy - Mayo Clinic

    ... Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo ...